Author

Alessia Burocchi

Observed name: Burocchi, Alessia

Institution: Nerviano Medical Sciences

Observed institutions: Nerviano Medical Sciences, Fondazione IRCCS Istituto Nazionale dei Tumori

ORCID: 0000-0001-8269-0460

Observed ORCID: 0000-0001-8269-0460

OpenAlex ID: A5061966627

Osteopontin Shapes Immunosuppression in the Metastatic Niche

2014 · Sabina Sangaletti, Claudio Tripodo, et al. · Cancer Research · 161

Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors

2017 · Chiara Ratti, Laura Botti, et al. · Clinical Cancer Research · 91

A non‐redundant role for OX40 in the competitive fitness of Treg in response to IL‐2

2010 · Silvia Piconese, Paola Pittoni, et al. · European Journal of Immunology · 67

PDF

Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient KitW-sh/W-sh mice

2011 · Silvia Piconese, Massimo Costanza, et al. · Laboratory Investigation · 64

PDF

Intratumor OX40 stimulation inhibits IRF1 expression and IL‐10 production by Treg cells while enhancing CD40L expression by effector memory T cells

2011 · Alessia Burocchi, Paola Pittoni, et al. · European Journal of Immunology · 56

PDF

Mast Cells Control the Expansion and Differentiation of IL-10–Competent B Cells

2014 · Francesca Mion, Federica D’Incà, et al. · The Journal of Immunology · 47

Persistent Immune Stimulation Exacerbates Genetically Driven Myeloproliferative Disorders via Stromal Remodeling

2017 · Claudio Tripodo, Alessia Burocchi, et al. · Cancer Research · 36

PDF

Mast Cells Infiltrating Inflamed or Transformed Gut Alternatively Sustain Mucosal Healing or Tumor Growth

2015 · Alice Rigoni, Lucia Bongiovanni, et al. · Cancer Research · 30

The matricellular protein SPARC supports follicular dendritic cell networking toward Th17 responses

2011 · Silvia Piconese, Massimo Costanza, et al. · Journal of Autoimmunity · 29

Regulated Expression of miR-155 is Required for iNKT Cell Development

2015 · Alessia Burocchi, Paola Pittoni, et al. · Frontiers in Immunology · 28

PDF

Convergences and Divergences of Thymus- and Peripherally Derived Regulatory T Cells in Cancer

2013 · Alessia Burocchi, Mario P. Colombo, et al. · Frontiers in Immunology · 25

PDF

Reciprocal influence of B cells and tumor macro and microenvironments in theApcMin/+model of colorectal cancer

2017 · Francesca Mion, Stefania Vetrano, et al. · OncoImmunology · 10

PDF

OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis

2018 · Patrizia Nanni, Carla De Giovanni, et al. · OncoImmunology · 8

Discovery and optimization of 4-pyrazolyl-2-aminopyrimidine derivatives as potent spleen tyrosine kinase (SYK) inhibitors

2024 · Giovanni Cervi, Roberto D'Alessio, et al. · European Journal of Medicinal Chemistry · 4

Abstract 5805: A novel platform of diversified payloads to drive ADC innovation

2024 · Paolo Orsini, Matteo Salsa, et al. · Cancer Research · 1

OX40 expression in tumor-associated Tregs as a potential prognostic biomarker and immunotherapeutic target in ovarian cancer.

2015 · Massimo A. Di Nicola, Roberta Zappasodi, et al. · Journal of Clinical Oncology · 1

Data from Persistent Immune Stimulation Exacerbates Genetically Driven Myeloproliferative Disorders via Stromal Remodeling

2023 · Claudio Tripodo, Alessia Burocchi, et al.

Supplementary Methods, Figures, and Tables from Persistent Immune Stimulation Exacerbates Genetically Driven Myeloproliferative Disorders via Stromal Remodeling

2023 · Claudio Tripodo, Alessia Burocchi, et al.

Fig.S4 from Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors